top of page
FAQs: Precursor Conditions Multiple Myeloma
![](https://static.wixstatic.com/media/cd6738_fd79f6c91156407cb6bb0fb631e6c309~mv2.jpeg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/cd6738_fd79f6c91156407cb6bb0fb631e6c309~mv2.webp)
![Multiple Myeloma Research Foundation - MMRF - Multiple Myeloma Precursor Conditions](https://static.wixstatic.com/media/cd6738_fd79f6c91156407cb6bb0fb631e6c309~mv2.jpeg/v1/fill/w_320,h_240,fp_0.50_0.50,q_90,enc_auto/cd6738_fd79f6c91156407cb6bb0fb631e6c309~mv2.webp)
Dec 15, 2021
Multiple Myeloma Research Foundation - MMRF - Multiple Myeloma Precursor Conditions
Multiple Myeloma Precursor Conditions: Find out the difference between monoclonal gammopathy of undetermined significance (MGUS) and...
91
![The Binding Site: Introducing the iStopMM Trial](https://static.wixstatic.com/media/cd6738_b0fd397d121f49e4bafee17c52f87f58~mv2.png/v1/fill/w_320,h_240,fp_0.50_0.50,q_95,enc_auto/cd6738_b0fd397d121f49e4bafee17c52f87f58~mv2.webp)
Jun 3, 2021
The Binding Site: Introducing the iStopMM Trial
The Binding Site: Introducing the iStopMM Trial The Binding Site: Introducing the iStopMM Trial Learn more: The Binding Site...
87
![](https://static.wixstatic.com/media/cd6738_39c46ca94603431d89f532558bbd4505~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/cd6738_39c46ca94603431d89f532558bbd4505~mv2.webp)
![Myeloma Canada: Patient Handbook - MGUS and Smoldering Multiple Myeloma](https://static.wixstatic.com/media/cd6738_39c46ca94603431d89f532558bbd4505~mv2.jpg/v1/fill/w_320,h_240,fp_0.50_0.50,q_90,enc_auto/cd6738_39c46ca94603431d89f532558bbd4505~mv2.webp)
Dec 19, 2020
Myeloma Canada: Patient Handbook - MGUS and Smoldering Multiple Myeloma
Myeloma Canada: Patient Handbook - MGUS and Smoldering Multiple Myeloma https://myeloma.ca/pixms/uploads/serve/ckeditor/mgus_and_smm_info...
115
![](https://static.wixstatic.com/media/cd6738_41846d8f5dcc4885bf450e83a730a4f2~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/cd6738_41846d8f5dcc4885bf450e83a730a4f2~mv2.webp)
![MGUS (Monoclonal gammopathy of undetermined significance) - > Smoldering Myeloma -> Multiple Myeloma](https://static.wixstatic.com/media/cd6738_41846d8f5dcc4885bf450e83a730a4f2~mv2.jpg/v1/fill/w_320,h_240,fp_0.50_0.50,q_90,enc_auto/cd6738_41846d8f5dcc4885bf450e83a730a4f2~mv2.webp)
Dec 10, 2020
MGUS (Monoclonal gammopathy of undetermined significance) - > Smoldering Myeloma -> Multiple Myeloma
MGUS (Monoclonal gammopathy of undetermined significance) - > Smoldering Myeloma -> Multiple Myeloma MGUS Diagnosis: Monoclonal...
164
![](https://static.wixstatic.com/media/cd6738_4ad75a598e524b2596ca40bcf0954d94~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/cd6738_4ad75a598e524b2596ca40bcf0954d94~mv2.webp)
![The 20/2/20 risk stratification model for Smoldering Myeloma](https://static.wixstatic.com/media/cd6738_4ad75a598e524b2596ca40bcf0954d94~mv2.jpg/v1/fill/w_320,h_240,fp_0.50_0.50,q_90,enc_auto/cd6738_4ad75a598e524b2596ca40bcf0954d94~mv2.webp)
Dec 1, 2020
The 20/2/20 risk stratification model for Smoldering Myeloma
Oncologists use 20/2/20 model to calculate risk score to predict progression risk to active myeloma at 2 years for each individual...
3,124
bottom of page